SCHEMBL7973752

SCHEMBL7973752

NC(=O)c1c(N)ncn1CCCOc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.47
LMNA P02545 3/20 0.47
ALOX15 P16050 1/20 0.47
TSHR P16473 1/20 0.47
PARP10 Q53GL7 1/20 0.47
KMT2A Q03164 2/20 0.45
GAA P10253 2/20 0.45
ALDH1A1 P00352 4/20 0.45
KDM4E B2RXH2 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.43
MAPT P10636 3/20 0.42
HTT P42858 3/20 0.42
TP53 P04637 1/20 0.42
RAB9A P51151 2/20 0.41
HPGD P15428 2/20 0.41
MEN1 O00255 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
ICMT O60725 2/20 0.41
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988146 0.93 GAA (0.51) SMN1; SMN2LMNAALOX15TSHRPARP10
SCHEMBL7992360 0.82 ADRA1D (0.46) SMN1; SMN2LMNATSHRKMT2AGAA
SCHEMBL2145646 0.80 GAA (0.51) SMN1; SMN2LMNAALOX15TSHRPARP10
SCHEMBL7988810 0.79 ADORA2A (0.51) TSHRKMT2AGAAALDH1A1HTT
SCHEMBL7987837 0.78 RECQL (0.47) SMN1; SMN2LMNAALOX15TSHRPARP10
SCHEMBL7984250 0.77 PARP10 (0.53) SMN1; SMN2TSHRPARP10GAAL3MBTL1
SCHEMBL7974495 0.77 ADORA2A (0.48) LMNAKMT2AGAAALDH1A1HPGD
SCHEMBL5483136 0.76 PKM (0.59) LMNATSHRGAAALDH1A1
SCHEMBL7988227 0.76 TLR8 (0.45) SMN1; SMN2KMT2AGAAALDH1A1L3MBTL1
Hydrochloric Acid SCHEMBL7987445 0.74 PKM (0.57) LMNATSHRGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed